Pro Medicus: Monsters Inc

About the author:

Author name:

By Iain Wilkie

Job title:

Research Analyst

Date posted:

27 September 2023, 7:00 AM

Sectors Covered:

Healthcare and Life Sciences

• Pro Medicus (ASX:PME) has signed its largest contract to date (by quite a distance), inking a A$140m contract over 10 years with a large US-based healthcare system.
• Outside of the material financial impact, the deal perhaps highlights the potential monster contracts which lurk beneath the opaque waters of the US healthcare system.
• We classify this contract as a one-off which doesn’t roll through our long-term new contract growth assumptions – but it does also bring into question how many potential deals sit between historical contract sizes and this new upper bound.
• We have rolled through the upgraded assumptions which takes our target price to (login to view) and retain our Hold recommendation. We still remain cautious purely on valuation grounds.

Find out more

If you would like more information, please contact your adviser or nearest Morgans office.

Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.